N/A
N=50
Evaluation of Smell and Taste in Fibromyalgia
Fibromyalgia
Bottom Line
View on ClinicalTrials.gov: NCT03823937 ↗Enrolled (actual)
50
Serious AEs
—
Results posted
Jun 2020
Primary outcome: Primary: Sniffin' Sticks Test Score — 25.96; 36.40 score on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Sniffin' Sticks test and Taste strips (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sniffin' Sticks Test Score |
25.96; 36.40 | — |
| PRIMARY Taste Strips Test Score |
9.93; 13.55 | — |
| SECONDARY Quality of Life Score |
0.452; 0.916 | — |
| SECONDARY Anxiety Score |
21.23; 5.45 | — |
| SECONDARY Alexithymia Score |
57.20; 46.80 | — |
| SECONDARY Depression Score |
18.03; 5.70 | — |
Summary
Patients diagnosed with fibromyalgia syndrome according to 2016 ACR criteria and 18-70 years old healthy subjects will be included in the study. Their smell and taste will be assessed with sniffin sticks and taste strips. Besides they will be evaluated for quality of life, anxiety, depression, and alexithymia.
Eligibility Criteria
Inclusion Criteria
- 18-70 years of fibromyalgia patients
- Giving informed consent
- Knowing how to write and read in Turkish
Exclusion Criteria
- Mentally retarded patients
- Psychiatric disorders (bipolar disorder, schizophrenia etc.)
- Severe organ failure (kidney, liver, heart failure)
- History of head trauma
- Any disorder associated with smell and taste functions
Data sourced from ClinicalTrials.gov (NCT03823937). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.